Agilent Technologies [A] vs Thermo Fisher [TMO] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Agilent Technologies Inc. wins in 9 metrics, Thermo Fisher Scientific Inc. wins in 11 metrics, with 0 ties. Thermo Fisher Scientific Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Agilent Technologies Inc. | Thermo Fisher Scientific Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 25.67 | 25.84 | Agilent Technologies Inc. |
| Price-to-Book Ratio | 4.76 | 3.31 | Thermo Fisher Scientific Inc. |
| Debt-to-Equity Ratio | 51.39 | 82.91 | Agilent Technologies Inc. |
| PEG Ratio | -7.19 | 2.29 | Thermo Fisher Scientific Inc. |
| EV/EBITDA | 17.32 | 19.02 | Agilent Technologies Inc. |
| Profit Margin (TTM) | 18.26% | 15.15% | Agilent Technologies Inc. |
| Operating Margin (TTM) | 22.86% | 17.89% | Agilent Technologies Inc. |
| EBITDA Margin (TTM) | 22.86% | 17.89% | Agilent Technologies Inc. |
| Return on Equity | 19.95% | 13.52% | Agilent Technologies Inc. |
| Return on Assets (TTM) | 8.53% | 5.00% | Agilent Technologies Inc. |
| Free Cash Flow (TTM) | $1.15B | $6.29B | Thermo Fisher Scientific Inc. |
| Dividend Yield | 0.68% | 0.38% | Agilent Technologies Inc. |
| 1-Year Return | 10.90% | 16.53% | Thermo Fisher Scientific Inc. |
| Price-to-Sales Ratio (TTM) | 4.65 | 3.86 | Thermo Fisher Scientific Inc. |
| Enterprise Value | $34.13B | $214.76B | Thermo Fisher Scientific Inc. |
| EV/Revenue Ratio | 4.83 | 4.75 | Thermo Fisher Scientific Inc. |
| Gross Profit Margin (TTM) | 52.61% | N/A | N/A |
| Revenue per Share (TTM) | $25 | $120 | Thermo Fisher Scientific Inc. |
| Earnings per Share (Diluted) | $4.53 | $18.18 | Thermo Fisher Scientific Inc. |
| Beta (Stock Volatility) | 1.30 | 0.97 | Thermo Fisher Scientific Inc. |
| Short % of Float | 1.83% | 1.22% | Thermo Fisher Scientific Inc. |
Agilent Technologies Inc. vs Thermo Fisher Scientific Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Agilent Technologies Inc. | -3.41% | -2.11% | 3.78% | 7.87% | -3.22% | -4.70% |
| Thermo Fisher Scientific Inc. | 0.93% | 0.87% | 8.07% | 0.79% | -17.74% | -20.05% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Agilent Technologies Inc. | 10.90% | 7.19% | -10.46% | 186.24% | 282.67% | 444.17% |
| Thermo Fisher Scientific Inc. | 16.53% | -12.65% | -2.72% | 220.94% | 654.32% | 1,231.84% |
Performance & Financial Health Analysis: Agilent Technologies Inc. vs Thermo Fisher Scientific Inc.
| Metric | A | TMO |
|---|---|---|
| Market Information | ||
| Market Cap | $32.65B | $174.55B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,922,585 | 2,356,220 |
| 90 Day Avg. Volume | 1,892,452 | 2,071,517 |
| Last Close | $131.46 | $473.72 |
| 52 Week Range | $108.35 - $160.27 | $385.46 - $643.99 |
| % from 52W High | -17.98% | -26.44% |
| All-Time High | $179.57 (Aug 30, 2021) | $672.34 (Dec 27, 2021) |
| % from All-Time High | -26.79% | -29.54% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.07% | 0.06% |
| Quarterly Earnings Growth | -0.04% | 0.10% |
| Financial Health | ||
| Profit Margin (TTM) | 0.18% | 0.15% |
| Operating Margin (TTM) | 0.23% | 0.18% |
| Return on Equity (TTM) | 0.20% | 0.14% |
| Debt to Equity (MRQ) | 51.39 | 82.91 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $24.44 | $141.96 |
| Cash per Share (MRQ) | $6.22 | $8.75 |
| Operating Cash Flow (TTM) | $1.40B | $8.29B |
| Levered Free Cash Flow (TTM) | $855.88M | $5.51B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.68% | 0.38% |
| Last 12-Month Dividend | $1.01 | $1.76 |
Valuation & Enterprise Metrics Analysis: Agilent Technologies Inc. vs Thermo Fisher Scientific Inc.
| Metric | A (Apr 26, 2026) | TMO (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 25.67 | 25.84 |
| Forward P/E | 17.67 | 17.16 |
| PEG Ratio | -7.19 | 2.29 |
| Price to Sales (TTM) | 4.65 | 3.86 |
| Price to Book (MRQ) | 4.76 | 3.31 |
| Market Capitalization | ||
| Market Capitalization | $32.65B | $174.55B |
| Enterprise Value | $34.13B | $214.76B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.83 | 4.75 |
| Enterprise to EBITDA | 17.32 | 19.02 |
| Risk & Other Metrics | ||
| Beta | 1.30 | 0.97 |
| Book Value per Share (MRQ) | $24.44 | $141.96 |
Financial Statements Comparison: Agilent Technologies Inc. vs Thermo Fisher Scientific Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | A (2025) | TMO (2025) |
|---|---|---|
| Revenue/Sales | 6.95B | 44.56B |
| Cost of Goods Sold | 3.31B | 26.32B |
| COGS % of Revenue | 47.6% | 59.1% |
| Gross Profit | 3.64B | 18.24B |
| Gross Margin | 52.4% | 40.9% |
| Research & Development | 455.00M | 1.40B |
| Operating Income (EBIT) | 1.48B | 8.11B |
| Operating Margin | 21.3% | 18.2% |
| EBITDA | 1.84B | 11.86B |
| EBITDA Margin | 26.4% | 26.6% |
| Pre-Tax Income | 1.44B | 7.31B |
| Pre-Tax Income % of Revenue | 20.7% | 16.4% |
| Income Tax | 132.00M | 547.00M |
| Income Tax % of Revenue | 1.9% | 1.2% |
| Net Income (Profit) | 1.30B | 6.72B |
| Profit Margin | 18.8% | 15.1% |
Balance Sheet & Liquidity Metrics
| Metric | A (2025) | TMO (2025) |
|---|---|---|
| Cash & Equivalents | 1.79B | 9.85B |
| Total Current Assets | 4.59B | 28.71B |
| Total Current Assets % of Revenue | 66.1% | 64.4% |
| Total Current Liabilities | 2.35B | 15.19B |
| Total Current Liabilities % of Revenue | 33.8% | 34.1% |
| Long-Term Debt | 3.05B | 35.85B |
| Long-Term Debt % of Revenue | 43.9% | 80.5% |
| Total Shareholders Equity | 6.74B | 53.54B |
| Retained Earnings | 1.39B | 59.16B |
| Retained Earnings % of Revenue | 20.0% | 132.8% |
| Property, Plant & Equipment | 0 | 0 |
Cash Flow Statement Comparison
| Metric | A (2025) | TMO (2025) |
|---|---|---|
| Operating Cash Flow | 1.51B | 7.82B |
| Operating Cash Flow % of Revenue | 21.7% | 17.5% |
| Capital Expenditures | -407.00M | -1.48B |
| Free Cash Flow | 1.15B | 6.29B |
| FCF Margin | 16.6% | 14.1% |
| Debt Repayment | -3.00M | -3.51B |
| Common Stock Repurchase | -425.00M | -3.00B |
Short Interest & Institutional Ownership Analysis
| Metric | A | TMO |
|---|---|---|
| Shares Short | 4.55M | 4.54M |
| Short Ratio | 1.93 | 2.38 |
| Short % of Float | 1.83% | 1.22% |
| Shares Outstanding | 282.70M | 371.62M |
| Float Shares | 281.64M | 371.07M |
| % Held by Insiders | 0.19% | 0.17% |
| % Held by Institutions | 93.87% | 95.23% |
| % Held by Public | 5.94% | 4.60% |
Dividend Analysis & Yield Comparison: Agilent Technologies Inc. vs Thermo Fisher Scientific Inc.
| Metric | A | TMO |
|---|---|---|
| Last 12-Month Dividend | $1.01 | $1.76 |
| Last 12-Month Dividend Yield | 0.68% | 0.38% |
| 3-Year Avg Annual Dividend | $0.97 | $1.60 |
| 3-Year Avg Dividend Yield | 0.18% | 0.08% |
| 3-Year Total Dividends | $2.91 | $4.80 |
| Ex-Dividend Date | Jan 06, 2026 | Mar 13, 2026 |